Table 1.
Characteristics of study groups (numbers of patients, unless indicated otherwise)
| Intervention group, N = 10 | Control group, N = 10 | |||
|---|---|---|---|---|
| Age (median, range) | 55 (32–75) | 64 (47–93) | ||
| Uterine cancer | Endometrial | 4 | 7 | |
| Carcinosarcoma | 1 | |||
| FIGO stage | IC G2 | 1 | ||
| IIA G2 | 1 | IC G3 | 1 | |
| IIIA | 1 | IIA G3 | 1 | |
| IIIC G2 | 1 | IIB G2 | 1 | |
| Recurrencea | 1 | IIIA G1 | 1 | |
| Carcinosarcoma IC | 1 | IVB | 1 | |
| Unknowna | 1 | |||
| Surgery | AUE + BSO | 3 | AUE + BSO | 4 |
| AUE ± LND | 1 | AUE ± LND | 2 | |
| AUE + BSO + LND | 1 | |||
| Postoperative RT (Grays) | (46) | 4 | (46) | 4 |
| (48.6) | 1 | (48.6) | 2 | |
| Primary RT (Grays) | (40.05) | 1 | ||
| Brachytherapy (Grays) | (10) | 3 | (10) | 5 |
| (12) | 1 | |||
| Chemotherapy | 2 | |||
| Cervical cancer | 5 | 3 | ||
| FIGO stage | IBI | 1 | IBI | 2 |
| IB2 | 1 | IIIB | 1 | |
| IIB | 2 | |||
| IIIB | 1 | |||
| Surgery | LNDebulking | 3 | RH + LND | 1 |
| VH | 1 | |||
| Postoperative RT (Grays) | (46) | 3 | (46) | 2 |
| Primary RT (Grays) | (46) | 2 | (46) | 1 |
| Brachytherapy (Grays) | (24) | 5 | (10) | 1 |
| (24) | 1 | |||
| (28) | 1 | |||
| Hyperthermia | 1 h/week | 1 | 1 | |
| Surdosage parametria/LN | 4 | 2 | ||
| Chemotherapy | 4 | 1 | ||
G grade of tumor cell differentiation, AUE abdominal hysterectomy, BSO bilateral salpingo-oophorectomy, LND lymph node dissection, RT radiotherapy, LNDebulking lymph node debulking, RH + LND radical hysterectomy and lymph node dissection, VH vaginal hysterectomy–cervical cancer was coincidentally found, FIGO international federation of gynaecologic oncology, LN lymph nodes
aRecurrence–previous treatment did not include radiotherapy, only AUE and BSO